PPA
RPRX icon

Parametric Portfolio Associates’s Royalty Pharma RPRX Stock Holding History

Parametric Portfolio Associates’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$15.4M Buy
394,985
+25,306
+7% +$994K 0.01% 1111
2021
Q4 		$14.7M Buy
369,679
+54,031
+17% +$2.1M 0.01% 1143
2021
Q3 		$11.4M Buy
315,648
+76,131
+32% +$2.96M 0.01% 1265
2021
Q2 		$9.82M Buy
239,517
+55,889
+30% +$2.38M 0.01% 1409
2021
Q1 		$8.01M Buy
183,628
+5,578
+3% +$264K ﹤0.01% 1838
2020
Q4 		$8.91M Buy
178,050
+158,211
+797% +$6.71M 0.01% 1657
2020
Q3 		$835K Buy
+19,839
New +$851K ﹤0.01% 3030

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return